Environmental sustainability and patient care go hand-in hand

At BD, we are committed to both.

In 2020, about 14.5 billion kilogrammes of healthcare plastics were produced across the globe.2* Across Europe, about 36% of healthcare waste is plastics.3

Healthcare's climate footprint is equivalent to 4.4% of global net emissions.4

If the healthcare sector were a country, it would be the fifth-largest emitter on the planet.4

Acute healthcare services are accountable for 56% of total emissions from clinical activity, equivalent to an estimated 125kg of CO2 emissions per day.5


Maureen Mazurek, Chief EHS & Sustainability Officer

Join Maureen Mazurek, in exploring the BD commitments to advancing the health of our planet, an integral part of our Together We Advance strategy, and our 2030+ goals.


Fiona Garin, Vice President, Strategic Marketing EMEA

Hear from Fiona Garin, on how BD strives to ensure access to safe, quality care for current and future generations while minimising negative impacts on the environment, all of which fall under our commitment to sustainable healthcare.

"The product with the least CO2 emissions is the product you don't use at all. There is a strong correlation between quality, value-based healthcare and green programmes. For every appointment that was not necessary and that someone is driven to, for every procedure that is not necessary and uses a lot of stuff, for every medicine that people are prescribed and don't take, you also waste a lot of carbon." ​


-Prof Hamish Laing, Director of the Value-Based Health and Care Academy, Swansea University​

Placeholder

Together we Advance

Under our Together We Advance strategy, we've made environmental, social and governance (ESG) commitments and set goals in specific areas where we see the most opportunity for BD to create meaningful, measurable change over the next decade and beyond.

These areas have the potential to create lasting impact on our company, our planet, our communities and human health.

Learn more about our ESG strategy and our 2030+ commitments:

DISCOVER THE BD ESG REPORT


United Nations Race to Zero

In joining the UN Race to Zero, BD has committed to setting science-based emissions reduction targets across all scopes, in line with 1.5°C emissions scenarios and the criteria and recommendations of the Science Based Targets initiative (SBTi).

  • Reduce Scope 1 and 2 emissions by 50% by 2030 (from 2019 baseline, absolute)
  • Achieve carbon-neutrality across direct operations by 2040
  • Scope 3 emission targets submitted to SBTi in 2023, pending validation

In 2022, BD formed the Sustainable Medical Technology Institute (SMTI), a dedicated R&D group that works to drive sustainability in all aspects of the BD product life cycle-from design to manufacturing, use and disposal.



Placeholder


Placeholder



Sustainability relies on efficiency

The efficient use of energy, natural, material and informational resources is vital for sustainability and sustainable development, which should be the major goal of every country.6

As a pillar of BD Signature Programmes, our Efficiency Programme was designed to help healthcare institutions minimise waste and inefficiencies to unlock their hidden capacity and drive financial & environmental sustainability.

Among its objectives, we aim to help build resilience and environmental stability, both of which can be bolstered by improving efficiency.


Our commitment in action

Could rethinking our processes help reduce our carbon footprint, while driving down financial pressures?

Across BD, we are bringing to life a vision of sustainable healthcare, for our planet and patients alike.

Discover some of our highlight initiatives:

Connected medication management (CMM)

CMM helps generate standardised, streamlined processes that drive efficiency and patient safety, enable hospital traceability and reduce medication errors, all of which help alleviate staff and boost hospital sustainability by addressing the major issue of medication waste and reducing energy consumption.

BD Signature Programme

BD Signature Programmes provide a holistic approach to addressing your institution's evolving needs, giving you direct, tailored access to our unique offering of technologies, services and capabilities.

Featured in the press

BD partnered with Odense University Hospital, the Health Innovation Centre of Southern Denmark, the Danish Technological Institute, the Global Material & Asset Fund and EcoFITT ApS to conduct a feasibility study, which focused on used blood collection tubes from laboratories. The study shows that these used tubes, which are made from high-quality polyethylene terephthalate (PET) plastic, can be cleaned, shredded and molded into other types of new articles.

Stay up-to-date on the lastest in healthcare sustainability and Dowload the latest ESG Report